Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-β-D-erythro-hexopyranosyl nucleosides
Identifieur interne : 001519 ( Istex/Corpus ); précédent : 001518; suivant : 001520Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-β-D-erythro-hexopyranosyl nucleosides
Auteurs : K. Augustyns ; G. Godard ; C. Hendrix ; A. Van Aerschot ; J. Rozenski ; T. Saison-Behmoaras ; P. HerdewijnSource :
- Nucleic Acids Research [ 0305-1048 ] ; 1993.
Abstract
Antisense oligonucleotides with a 2,4-dideoxyhexopyranosyl nucleoside incorporated at the 3'-end and at a mutation site of the Ha-ras oncogene mRNA were synthesized. Melting temperature studies revealed that an A*-G mismatch is more stable than an A*-T mismatch with these hexopyranosyl nucleosides incorporated at the mutation site. The oligonucleotides are stable against enzymatic degradation. RNase H mediated cleavage studies revealed selective cleavage of mutated Ha-ras mRNA. The oligonucleotide containing two pyranose nucleosides at the penultimate position activates RNase H more strongly than natural oligonucleotides. No correlation, however, was found between DNA-DNA or RNA-DNA melting temperatures and RNase H mediated cleavage capacity. Although the A*-G mismatch gives more stable hybridization than the A*-T base pairing, only the oligonucleotides containing an A*-T base pair are recognized by RNase H. This modification is situated 3 base pairs upstream to the cleavage site. Finally, the double pyranose modified oligonucleotide was able to reduce the growth of T24 cells (bladder carcinoma) while the unmodified antisense oligonucleotide was not.
Url:
DOI: 10.1093/nar/21.20.4670
Links to Exploration step
ISTEX:7A20AA50114BEDA62F7B1EFDE2DC140F8C6399E9Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-β-D-erythro-hexopyranosyl nucleosides</title>
<author><name sortKey="Augustyns, K" sort="Augustyns, K" uniqKey="Augustyns K" first="K." last="Augustyns">K. Augustyns</name>
<affiliation><mods:affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Godard, G" sort="Godard, G" uniqKey="Godard G" first="G." last="Godard">G. Godard</name>
<affiliation><mods:affiliation>Museum National d'Histoire Naturelle, Laboratoire de Biophysique 43, rue Cuvier, F-75231 Paris Cedex 05, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Hendrix, C" sort="Hendrix, C" uniqKey="Hendrix C" first="C." last="Hendrix">C. Hendrix</name>
<affiliation><mods:affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Van Aerschot, A" sort="Van Aerschot, A" uniqKey="Van Aerschot A" first="A." last="Van Aerschot">A. Van Aerschot</name>
<affiliation><mods:affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Rozenski, J" sort="Rozenski, J" uniqKey="Rozenski J" first="J." last="Rozenski">J. Rozenski</name>
<affiliation><mods:affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Saison Behmoaras, T" sort="Saison Behmoaras, T" uniqKey="Saison Behmoaras T" first="T." last="Saison-Behmoaras">T. Saison-Behmoaras</name>
<affiliation><mods:affiliation>Museum National d'Histoire Naturelle, Laboratoire de Biophysique 43, rue Cuvier, F-75231 Paris Cedex 05, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Herdewijn, P" sort="Herdewijn, P" uniqKey="Herdewijn P" first="P." last="Herdewijn">P. Herdewijn</name>
<affiliation><mods:affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>*To whom the correspondence should be sent</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7A20AA50114BEDA62F7B1EFDE2DC140F8C6399E9</idno>
<date when="1993" year="1993">1993</date>
<idno type="doi">10.1093/nar/21.20.4670</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-PJZP6NV7-B/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001519</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001519</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-β-D-erythro-hexopyranosyl nucleosides</title>
<author><name sortKey="Augustyns, K" sort="Augustyns, K" uniqKey="Augustyns K" first="K." last="Augustyns">K. Augustyns</name>
<affiliation><mods:affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Godard, G" sort="Godard, G" uniqKey="Godard G" first="G." last="Godard">G. Godard</name>
<affiliation><mods:affiliation>Museum National d'Histoire Naturelle, Laboratoire de Biophysique 43, rue Cuvier, F-75231 Paris Cedex 05, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Hendrix, C" sort="Hendrix, C" uniqKey="Hendrix C" first="C." last="Hendrix">C. Hendrix</name>
<affiliation><mods:affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Van Aerschot, A" sort="Van Aerschot, A" uniqKey="Van Aerschot A" first="A." last="Van Aerschot">A. Van Aerschot</name>
<affiliation><mods:affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Rozenski, J" sort="Rozenski, J" uniqKey="Rozenski J" first="J." last="Rozenski">J. Rozenski</name>
<affiliation><mods:affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Saison Behmoaras, T" sort="Saison Behmoaras, T" uniqKey="Saison Behmoaras T" first="T." last="Saison-Behmoaras">T. Saison-Behmoaras</name>
<affiliation><mods:affiliation>Museum National d'Histoire Naturelle, Laboratoire de Biophysique 43, rue Cuvier, F-75231 Paris Cedex 05, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Herdewijn, P" sort="Herdewijn, P" uniqKey="Herdewijn P" first="P." last="Herdewijn">P. Herdewijn</name>
<affiliation><mods:affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>*To whom the correspondence should be sent</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Nucleic Acids Research</title>
<idno type="eISSN">1362-4962</idno>
<idno type="ISSN">0305-1048</idno>
<imprint><publisher>Oxford University Press</publisher>
<date type="published">1993</date>
<biblScope unit="vol">21</biblScope>
<biblScope unit="issue">20</biblScope>
<biblScope unit="page" from="4670">4670</biblScope>
<biblScope unit="page" to="4676">4676</biblScope>
</imprint>
<idno type="ISSN">0305-1048</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0305-1048</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">Antisense oligonucleotides with a 2,4-dideoxyhexopyranosyl nucleoside incorporated at the 3'-end and at a mutation site of the Ha-ras oncogene mRNA were synthesized. Melting temperature studies revealed that an A*-G mismatch is more stable than an A*-T mismatch with these hexopyranosyl nucleosides incorporated at the mutation site. The oligonucleotides are stable against enzymatic degradation. RNase H mediated cleavage studies revealed selective cleavage of mutated Ha-ras mRNA. The oligonucleotide containing two pyranose nucleosides at the penultimate position activates RNase H more strongly than natural oligonucleotides. No correlation, however, was found between DNA-DNA or RNA-DNA melting temperatures and RNase H mediated cleavage capacity. Although the A*-G mismatch gives more stable hybridization than the A*-T base pairing, only the oligonucleotides containing an A*-T base pair are recognized by RNase H. This modification is situated 3 base pairs upstream to the cleavage site. Finally, the double pyranose modified oligonucleotide was able to reduce the growth of T24 cells (bladder carcinoma) while the unmodified antisense oligonucleotide was not.</div>
</front>
</TEI>
<istex><corpusName>oup</corpusName>
<keywords><teeft><json:string>oligonucleotide</json:string>
<json:string>oligonucleotides</json:string>
<json:string>mrna</json:string>
<json:string>mmol</json:string>
<json:string>nucleoside</json:string>
<json:string>rnase</json:string>
<json:string>oncogene</json:string>
<json:string>antisense</json:string>
<json:string>mutation</json:string>
<json:string>mismatch</json:string>
<json:string>mutation site</json:string>
<json:string>hexose</json:string>
<json:string>dmtr</json:string>
<json:string>hybridization</json:string>
<json:string>duplex</json:string>
<json:string>pyranose</json:string>
<json:string>base pair</json:string>
<json:string>cleavage</json:string>
<json:string>antisense oligonucleotides</json:string>
<json:string>nucleic</json:string>
<json:string>hexose nucleoside</json:string>
<json:string>nucleic acid research</json:string>
<json:string>title compound</json:string>
<json:string>selective inhibition</json:string>
<json:string>dmtr dmtr</json:string>
<json:string>enzymatic stability</json:string>
<json:string>hexopyranosyl nucleoside</json:string>
<json:string>unmodified</json:string>
<json:string>cleavage site</json:string>
<json:string>building block</json:string>
<json:string>potassium phosphate</json:string>
<json:string>enzymatic degradation</json:string>
<json:string>more stable</json:string>
<json:string>room temperature</json:string>
<json:string>column chromatography</json:string>
<json:string>dimethoxytrityl chloride</json:string>
<json:string>nucleic acid</json:string>
<json:string>aromatic signal</json:string>
<json:string>white powder</json:string>
<json:string>bladder carcinoma</json:string>
</teeft>
</keywords>
<author><json:item><name>K. Augustyns</name>
<affiliations><json:string>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</json:string>
</affiliations>
</json:item>
<json:item><name>G. Godard</name>
<affiliations><json:string>Museum National d'Histoire Naturelle, Laboratoire de Biophysique 43, rue Cuvier, F-75231 Paris Cedex 05, France</json:string>
</affiliations>
</json:item>
<json:item><name>C. Hendrix</name>
<affiliations><json:string>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</json:string>
</affiliations>
</json:item>
<json:item><name>A. Van Aerschot</name>
<affiliations><json:string>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</json:string>
</affiliations>
</json:item>
<json:item><name>J. Rozenski</name>
<affiliations><json:string>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</json:string>
</affiliations>
</json:item>
<json:item><name>T. Saison-Behmoaras</name>
<affiliations><json:string>Museum National d'Histoire Naturelle, Laboratoire de Biophysique 43, rue Cuvier, F-75231 Paris Cedex 05, France</json:string>
</affiliations>
</json:item>
<json:item><name>P. Herdewijn</name>
<affiliations><json:string>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</json:string>
<json:string>*To whom the correspondence should be sent</json:string>
</affiliations>
</json:item>
</author>
<articleId><json:string>21.20.4670</json:string>
</articleId>
<arkIstex>ark:/67375/HXZ-PJZP6NV7-B</arkIstex>
<language><json:string>unknown</json:string>
</language>
<originalGenre><json:string>research-article</json:string>
</originalGenre>
<abstract>Antisense oligonucleotides with a 2,4-dideoxyhexopyranosyl nucleoside incorporated at the 3'-end and at a mutation site of the Ha-ras oncogene mRNA were synthesized. Melting temperature studies revealed that an A*-G mismatch is more stable than an A*-T mismatch with these hexopyranosyl nucleosides incorporated at the mutation site. The oligonucleotides are stable against enzymatic degradation. RNase H mediated cleavage studies revealed selective cleavage of mutated Ha-ras mRNA. The oligonucleotide containing two pyranose nucleosides at the penultimate position activates RNase H more strongly than natural oligonucleotides. No correlation, however, was found between DNA-DNA or RNA-DNA melting temperatures and RNase H mediated cleavage capacity. Although the A*-G mismatch gives more stable hybridization than the A*-T base pairing, only the oligonucleotides containing an A*-T base pair are recognized by RNase H. This modification is situated 3 base pairs upstream to the cleavage site. Finally, the double pyranose modified oligonucleotide was able to reduce the growth of T24 cells (bladder carcinoma) while the unmodified antisense oligonucleotide was not.</abstract>
<qualityIndicators><score>7.125</score>
<pdfWordCount>3848</pdfWordCount>
<pdfCharCount>25095</pdfCharCount>
<pdfVersion>1.5</pdfVersion>
<pdfPageCount>7</pdfPageCount>
<pdfPageSize>584 x 785 pts</pdfPageSize>
<pdfWordsPerPage>550</pdfWordsPerPage>
<pdfText>true</pdfText>
<refBibsNative>false</refBibsNative>
<abstractWordCount>162</abstractWordCount>
<abstractCharCount>1168</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-β-D-erythro-hexopyranosyl nucleosides</title>
<pmid><json:string>7694231</json:string>
</pmid>
<genre><json:string>research-article</json:string>
</genre>
<host><title>Nucleic Acids Research</title>
<language><json:string>unknown</json:string>
</language>
<issn><json:string>0305-1048</json:string>
</issn>
<eissn><json:string>1362-4962</json:string>
</eissn>
<publisherId><json:string>nar</json:string>
</publisherId>
<volume>21</volume>
<issue>20</issue>
<pages><first>4670</first>
<last>4676</last>
</pages>
<genre><json:string>journal</json:string>
</genre>
<subject><json:item><value>CHEMISTRY</value>
</json:item>
</subject>
</host>
<namedEntities><unitex><date><json:string>1993</json:string>
<json:string>7500, 8500</json:string>
</date>
<geogName></geogName>
<orgName><json:string>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat</json:string>
<json:string>Belgian National Fund of Scientific Research</json:string>
<json:string>France Received</json:string>
<json:string>Belgian F</json:string>
</orgName>
<orgName_funder><json:string>Belgian F</json:string>
</orgName_funder>
<orgName_provider></orgName_provider>
<persName><json:string>T.Saison-Behmoaras</json:string>
<json:string>C.Hendrix</json:string>
<json:string>Paris Cedex</json:string>
<json:string>J.Rozenski</json:string>
<json:string>Dominique Brabants</json:string>
<json:string>G.Godard</json:string>
<json:string>A. Van</json:string>
<json:string>P.Herdewijn</json:string>
<json:string>A.Van Aerschot</json:string>
<json:string>Guy Schepers</json:string>
</persName>
<placeName><json:string>Belgium</json:string>
</placeName>
<ref_url></ref_url>
<ref_bibl><json:string>Saison et al.</json:string>
<json:string>Chang et al.</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark><json:string>ark:/67375/HXZ-PJZP6NV7-B</json:string>
</ark>
<categories><wos><json:string>1 - science</json:string>
<json:string>2 - biochemistry & molecular biology</json:string>
</wos>
<scienceMetrix><json:string>1 - health sciences</json:string>
<json:string>2 - biomedical research</json:string>
<json:string>3 - developmental biology</json:string>
</scienceMetrix>
<scopus><json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Genetics</json:string>
</scopus>
<inist><json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences biologiques fondamentales et appliquees. psychologie</json:string>
</inist>
</categories>
<publicationDate>1993</publicationDate>
<copyrightDate>1993</copyrightDate>
<doi><json:string>10.1093/nar/21.20.4670</json:string>
</doi>
<id>7A20AA50114BEDA62F7B1EFDE2DC140F8C6399E9</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/HXZ-PJZP6NV7-B/fulltext.pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/HXZ-PJZP6NV7-B/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/HXZ-PJZP6NV7-B/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-β-D-erythro-hexopyranosyl nucleosides</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Oxford University Press</publisher>
<availability><licence>© 1993 Oxford University Press</licence>
</availability>
<date type="Copyright" when="1993">1993</date>
<date type="published">1993</date>
</publicationStmt>
<notesStmt><note type="content-type" source="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note>
<note type="publication-type" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-β-D-erythro-hexopyranosyl nucleosides</title>
<author xml:id="author-0000"><persName><surname>Augustyns</surname>
<forename type="first">K.</forename>
</persName>
</author>
<author xml:id="author-0001"><persName><surname>Godard</surname>
<forename type="first">G.</forename>
</persName>
<affiliation><orgName type="institution">Museum National d'Histoire Naturelle, Laboratoire de Biophysique</orgName>
<address><addrLine>43, rue Cuvier, F-75231 Paris Cedex 05, France</addrLine>
</address>
</affiliation>
</author>
<author xml:id="author-0002"><persName><surname>Hendrix</surname>
<forename type="first">C.</forename>
</persName>
</author>
<author xml:id="author-0003"><persName><surname>Van Aerschot</surname>
<forename type="first">A.</forename>
</persName>
</author>
<author xml:id="author-0004"><persName><surname>Rozenski</surname>
<forename type="first">J.</forename>
</persName>
</author>
<author xml:id="author-0005"><persName><surname>Saison-Behmoaras</surname>
<forename type="first">T.</forename>
</persName>
<affiliation><orgName type="institution">Museum National d'Histoire Naturelle, Laboratoire de Biophysique</orgName>
<address><addrLine>43, rue Cuvier, F-75231 Paris Cedex 05, France</addrLine>
</address>
</affiliation>
</author>
<author xml:id="author-0006"><persName><surname>Herdewijn</surname>
<forename type="first">P.</forename>
</persName>
<affiliation role="corresp">*To whom the correspondence should be sent</affiliation>
</author>
<idno type="istex">7A20AA50114BEDA62F7B1EFDE2DC140F8C6399E9</idno>
<idno type="ark">ark:/67375/HXZ-PJZP6NV7-B</idno>
<idno type="publisher-id">21.20.4670</idno>
<idno type="DOI">10.1093/nar/21.20.4670</idno>
</analytic>
<monogr><title level="j" type="main">Nucleic Acids Research</title>
<idno type="hwp">nar</idno>
<idno type="publisher-id">nar</idno>
<idno type="pmc">nar</idno>
<idno type="eISSN">1362-4962</idno>
<idno type="pISSN">0305-1048</idno>
<imprint><publisher>Oxford University Press</publisher>
<date type="published">1993</date>
<biblScope unit="vol">21</biblScope>
<biblScope unit="issue">20</biblScope>
<biblScope unit="page" from="4670">4670</biblScope>
<biblScope unit="page" to="4676">4676</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef>
<appInfo><application ident="pub2tei" version="1.0.41" when="2020-04-06"><label>pub2TEI-ISTEX</label>
<desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref>
</desc>
</application>
</appInfo>
</encodingDesc>
<profileDesc><abstract><p>Antisense oligonucleotides with a 2,4-dideoxyhexopyranosyl nucleoside incorporated at the 3'-end and at a mutation site of the Ha-ras oncogene mRNA were synthesized. Melting temperature studies revealed that an A<hi rend="superscript">*</hi>
-G mismatch is more stable than an A<hi rend="superscript">*</hi>
-T mismatch with these hexopyranosyl nucleosides incorporated at the mutation site. The oligonucleotides are stable against enzymatic degradation. RNase H mediated cleavage studies revealed selective cleavage of mutated Ha-ras mRNA. The oligonucleotide containing two pyranose nucleosides at the penultimate position activates RNase H more strongly than natural oligonucleotides. No correlation, however, was found between DNA-DNA or RNA-DNA melting temperatures and RNase H mediated cleavage capacity. Although the A<hi rend="superscript">*</hi>
-G mismatch gives more stable hybridization than the A<hi rend="superscript">*</hi>
-T base pairing, only the oligonucleotides containing an A<hi rend="superscript">*</hi>
-T base pair are recognized by RNase H. This modification is situated 3 base pairs upstream to the cleavage site. Finally, the double pyranose modified oligonucleotide was able to reduce the growth of T24 cells (bladder carcinoma) while the unmodified antisense oligonucleotide was not.</p>
</abstract>
<textClass ana="subject"><keywords scheme="subject"><term>CHEMISTRY</term>
</keywords>
</textClass>
<langUsage><language ident="EN"></language>
</langUsage>
</profileDesc>
<revisionDesc><change when="2020-04-06" who="#istex" xml:id="pub2tei">formatting</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/HXZ-PJZP6NV7-B/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="corpus oup, element #text not found" wicri:toSee="no header"><istex:docType PUBLIC="-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" URI="journalpublishing.dtd" name="istex:docType"></istex:docType>
<istex:document><article article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="hwp">nar</journal-id>
<journal-id journal-id-type="publisher-id">nar</journal-id>
<journal-id journal-id-type="pmc">nar</journal-id>
<journal-title>Nucleic Acids Research</journal-title>
<issn pub-type="epub">1362-4962</issn>
<issn pub-type="ppub">0305-1048</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">21.20.4670</article-id>
<article-id pub-id-type="doi">10.1093/nar/21.20.4670</article-id>
<article-categories>
<subj-group>
<subject>CHEMISTRY</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-β-D-erythro-hexopyranosyl nucleosides</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Augustyns</surname>
<given-names>K.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name><surname>Godard</surname>
<given-names>G.</given-names>
</name>
<xref ref-type="aff" rid="au1"></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hendrix</surname>
<given-names>C.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name><surname>Van Aerschot</surname>
<given-names>A.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name><surname>Rozenski</surname>
<given-names>J.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name><surname>Saison-Behmoaras</surname>
<given-names>T.</given-names>
</name>
<xref ref-type="aff" rid="au1"></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Herdewijn</surname>
<given-names>P.</given-names>
</name>
<xref ref-type="corresp" rid="cor1"><sup>*</sup>
</xref>
</contrib>
<aff><institution>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven</institution>
<addr-line>Minderbroedersstraat 10, B-3000 Leuven, Belgium</addr-line>
</aff>
<aff id="au1"><institution>Museum National d'Histoire Naturelle, Laboratoire de Biophysique</institution>
<addr-line>43, rue Cuvier, F-75231 Paris Cedex 05, France</addr-line>
</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>*</sup>
To whom the correspondence should be sent</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>11</day>
<month>10</month>
<year>1993</year>
</pub-date>
<volume>21</volume>
<issue>20</issue>
<fpage>4670</fpage>
<lpage>4676</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>8</month>
<year>1993</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>9</month>
<year>1993</year>
</date>
<date date-type="rev-recd">
<day>03</day>
<month>9</month>
<year>1993</year>
</date>
</history>
<copyright-statement>© 1993 Oxford University Press</copyright-statement>
<copyright-year>1993</copyright-year>
<abstract>
<p>Antisense oligonucleotides with a 2,4-dideoxyhexopyranosyl nucleoside incorporated at the 3'-end and at a mutation site of the Ha-ras oncogene mRNA were synthesized. Melting temperature studies revealed that an A<sup>*</sup>
-G mismatch is more stable than an A<sup>*</sup>
-T mismatch with these hexopyranosyl nucleosides incorporated at the mutation site. The oligonucleotides are stable against enzymatic degradation. RNase H mediated cleavage studies revealed selective cleavage of mutated Ha-ras mRNA. The oligonucleotide containing two pyranose nucleosides at the penultimate position activates RNase H more strongly than natural oligonucleotides. No correlation, however, was found between DNA-DNA or RNA-DNA melting temperatures and RNase H mediated cleavage capacity. Although the A<sup>*</sup>
-G mismatch gives more stable hybridization than the A<sup>*</sup>
-T base pairing, only the oligonucleotides containing an A<sup>*</sup>
-T base pair are recognized by RNase H. This modification is situated 3 base pairs upstream to the cleavage site. Finally, the double pyranose modified oligonucleotide was able to reduce the growth of T24 cells (bladder carcinoma) while the unmodified antisense oligonucleotide was not.</p>
</abstract>
</article-meta>
</front>
</article>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo><title>Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-β-D-erythro-hexopyranosyl nucleosides</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA"><title>Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-β-D-erythro-hexopyranosyl nucleosides</title>
</titleInfo>
<name type="personal"><namePart type="given">K.</namePart>
<namePart type="family">Augustyns</namePart>
<affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G.</namePart>
<namePart type="family">Godard</namePart>
<affiliation>Museum National d'Histoire Naturelle, Laboratoire de Biophysique 43, rue Cuvier, F-75231 Paris Cedex 05, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C.</namePart>
<namePart type="family">Hendrix</namePart>
<affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A.</namePart>
<namePart type="family">Van Aerschot</namePart>
<affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J.</namePart>
<namePart type="family">Rozenski</namePart>
<affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T.</namePart>
<namePart type="family">Saison-Behmoaras</namePart>
<affiliation>Museum National d'Histoire Naturelle, Laboratoire de Biophysique 43, rue Cuvier, F-75231 Paris Cedex 05, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">P.</namePart>
<namePart type="family">Herdewijn</namePart>
<affiliation>Rega Institute for Medical Research, Laboratory of Medicinal Chemistry, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 43, rue Cuvier, F-75231 Paris Cedex 05, France</affiliation>
<affiliation>*To whom the correspondence should be sent</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="research-article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre>
<originInfo><publisher>Oxford University Press</publisher>
<dateIssued encoding="w3cdtf">1993-10-11</dateIssued>
<dateCreated encoding="w3cdtf">1993-09-03</dateCreated>
<copyrightDate encoding="w3cdtf">1993</copyrightDate>
</originInfo>
<abstract>Antisense oligonucleotides with a 2,4-dideoxyhexopyranosyl nucleoside incorporated at the 3'-end and at a mutation site of the Ha-ras oncogene mRNA were synthesized. Melting temperature studies revealed that an A*-G mismatch is more stable than an A*-T mismatch with these hexopyranosyl nucleosides incorporated at the mutation site. The oligonucleotides are stable against enzymatic degradation. RNase H mediated cleavage studies revealed selective cleavage of mutated Ha-ras mRNA. The oligonucleotide containing two pyranose nucleosides at the penultimate position activates RNase H more strongly than natural oligonucleotides. No correlation, however, was found between DNA-DNA or RNA-DNA melting temperatures and RNase H mediated cleavage capacity. Although the A*-G mismatch gives more stable hybridization than the A*-T base pairing, only the oligonucleotides containing an A*-T base pair are recognized by RNase H. This modification is situated 3 base pairs upstream to the cleavage site. Finally, the double pyranose modified oligonucleotide was able to reduce the growth of T24 cells (bladder carcinoma) while the unmodified antisense oligonucleotide was not.</abstract>
<note type="author-notes">*To whom the correspondence should be sent</note>
<relatedItem type="host"><titleInfo><title>Nucleic Acids Research</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<subject><topic>CHEMISTRY</topic>
</subject>
<identifier type="ISSN">0305-1048</identifier>
<identifier type="eISSN">1362-4962</identifier>
<identifier type="PublisherID">nar</identifier>
<identifier type="PublisherID-hwp">nar</identifier>
<part><date>1993</date>
<detail type="volume"><caption>vol.</caption>
<number>21</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>20</number>
</detail>
<extent unit="pages"><start>4670</start>
<end>4676</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">7A20AA50114BEDA62F7B1EFDE2DC140F8C6399E9</identifier>
<identifier type="ark">ark:/67375/HXZ-PJZP6NV7-B</identifier>
<identifier type="DOI">10.1093/nar/21.20.4670</identifier>
<identifier type="ArticleID">21.20.4670</identifier>
<accessCondition type="use and reproduction" contentType="copyright">© 1993 Oxford University Press</accessCondition>
<recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-GTWS0RDP-M">oup</recordContentSource>
<recordOrigin>Converted from (version 1.2.10) to MODS version 3.6.</recordOrigin>
<recordCreationDate encoding="w3cdtf">2020-04-16</recordCreationDate>
</recordInfo>
</mods>
<json:item><extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/HXZ-PJZP6NV7-B/record.json</uri>
</json:item>
</metadata>
<annexes><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/HXZ-PJZP6NV7-B/annexes.pdf</uri>
</json:item>
</annexes>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001519 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001519 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:7A20AA50114BEDA62F7B1EFDE2DC140F8C6399E9 |texte= Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-β-D-erythro-hexopyranosyl nucleosides }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |